INZY

Inozyme Pharma
INZY

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

53 hedge funds and large institutions have $428M invested in Inozyme Pharma in 2020 Q3 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$67.5M
2
+$64.3M
3
+$53.3M
4
RCM
RA Capital Management
Massachusetts
+$52.7M
5
DM
Deerfield Management
New York
+$30.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$67.5M
2
$64.3M
3
$53.3M
4
$52.7M
5
$30.2M
6
$26.5M
7
$23.1M
8
$21M
9
$16M
10
$13.2M
11
$10.5M
12
$8.01M
13
$7.81M
14
$6.34M
15
$5.16M
16
$3.12M
17
$2.98M
18
$2.58M
19
$2.44M
20
$1.86M
21
$1.63M
22
$1.27M
23
$633K
24
$509K
25
$449K
1
2 3